<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04677348</url>
  </required_header>
  <id_info>
    <org_study_id>2020-1822</org_study_id>
    <nct_id>NCT04677348</nct_id>
  </id_info>
  <brief_title>Comparison of PENG Block and FICB in Hip Fracture Patients</brief_title>
  <official_title>Comparison of Analgesic Effect of Pericapsular Nerve Group Block and Suprainguinal Fascia Iliaca Compartment Block on Dynamic Pain in Patients Undergoing Hip Fracture Surgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fascia iliaca compartment block (FICB) has been considered the block of choice for patients&#xD;
      with hip fracture. However, pericapsular nerve group (PENG) block, one of the relatively&#xD;
      newly-developed blocks, could be also used for analgesia in patients with hip fracture. Since&#xD;
      PENG block could block the accessory obturator nerve, PENG block might have greater analgesic&#xD;
      effects compared to FICB theoretically. However, the comparison of these two blocks in&#xD;
      patients with hip fracture has not performed in clinical setting. Thus, we aimed to compare&#xD;
      the analgesic effect of PENG block and FICB.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 14, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of each block (Pain score)</measure>
    <time_frame>before surgery</time_frame>
    <description>We will assess the dynamic pain (pain during a movement) using NRS before and 20-30min after applying the assigned block. Then, we will calculate the change of NRS at the two time-points.&#xD;
NRS: Numerical rating scale (0, no pain; 10, the worst pain imaginable)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change of blood pressure (systolic, diastolic, mean blood pressure)</measure>
    <time_frame>before surgery</time_frame>
    <description>We will evaluate the blood pressure before and 20-30min after applying the assigned block. Then, we will calculate the change of blood pressure at the two time-points.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain score</measure>
    <time_frame>postoperative 6, 24, 48hours</time_frame>
    <description>resting and dynamic pain using NRS at postoperative 6, 24, 48hours&#xD;
NRS: Numerical rating scale (0, no pain; 10, the worst pain imaginable)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative opioid consumption</measure>
    <time_frame>postoperative 24, 48hours</time_frame>
    <description>morphine-equivalent dose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative motor function</measure>
    <time_frame>postoperative 6, 24, 48hours</time_frame>
    <description>motor function of quadriceps femoris&#xD;
grade5: normal power grade4: movement possible against some resistance grade3: movement against gravity but not resistance grade2: movement possible if gravity eliminated grade1: flicker of contraction possible grade0: complete paralysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of heart rate</measure>
    <time_frame>before surgery</time_frame>
    <description>We will evaluate the heart rate before and 20-30 min after applying the assigned block. Then, we will calculate the change of heart rate at the two time-points.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Hip Fractures</condition>
  <condition>Regional Anesthesia</condition>
  <arm_group>
    <arm_group_label>PENG group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pericapsular nerve group (PENG) block before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FICB group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>suprainguinal fascia iliaca compartment block (FICB) before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pericapsular nerve group (PENG) block</intervention_name>
    <description>ultrasound-guided PENG block with 0.3% ropivacaine 20cc</description>
    <arm_group_label>PENG group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fascia iliaca compartment block (FICB)</intervention_name>
    <description>ultrasound-guided suprainguinal FICB with 0.3% ropivacaine 30cc</description>
    <arm_group_label>FICB group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA PS 1-4&#xD;
&#xD;
          -  age: ≥19&#xD;
&#xD;
          -  baseline pain score (associated with hip fracture): ≥4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients who do not agree to participate in this study&#xD;
&#xD;
          -  patients with uncontrolled hypertension, hyperthyroidism, severe dementia&#xD;
&#xD;
          -  allergic to ropivacaine&#xD;
&#xD;
          -  contraindicated to spinal anesthesia due to coagulopathy, severe aortic&#xD;
             stenosis/mitral stenosis, or active infection on lumbar region&#xD;
&#xD;
          -  patients who are considered ineligible with any other reason by investigators&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Won Uk Koh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ha-Jung Kim, MD, PhD</last_name>
    <phone>82-2-3010-0338</phone>
    <email>alexakim06@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 10, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>December 20, 2020</last_update_submitted>
  <last_update_submitted_qc>December 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Hajung Kim</investigator_full_name>
    <investigator_title>Clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>pericapsular nerve group block</keyword>
  <keyword>fascia iliaca compartment block</keyword>
  <keyword>hip fracture</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>dynamic pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

